MG217 Psoriasis Medicated Conditioning

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: MG217 Psoriasis Medicated Conditioning
Generic name: COAL TAR
Manufacturer: Wisconsin Pharmacal Company
Product type: HUMAN OTC DRUG
SPL set ID: 7cafb511-0ab7-f3b4-e053-2991aa0a2e0b
SPL ID: 7cafb511-0ab8-f3b4-e053-2991aa0a2e0b
Version: 1
Effective date: 2018-12-10
Source export date: 2026-10-12
Source partition: 11
Source file: https://download.open.fda.gov/drug/label/drug-label-0011-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-12/a497e765d824a2e2aa9e88d5f0eea2aae9dcba363989e5f163395cda5c3c9dd8/drug-label-0011-of-0014.json.zip
Source manifest SHA-256: 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run: 20261013T011858Z
Imported at: 2026-10-13 02:46:12

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 13 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		part358H	openfda.application_number
brand name		MG217 Psoriasis Medicated Conditioning	openfda.brand_name
generic name		COAL TAR	openfda.generic_name
manufacturer name		Wisconsin Pharmacal Company	openfda.manufacturer_name
ndc	package	68093-7232-2	openfda.package_ndc
ndc	package	68093-7232-1	openfda.package_ndc
ndc	product	68093-7232	openfda.product_ndc
ndc11	package	68093723202	derived:openfda.package_ndc
ndc11	package	68093723201	derived:openfda.package_ndc
rxcui		205100	openfda.rxcui
spl id		7cafb511-0ab8-f3b4-e053-2991aa0a2e0b	id
spl set id		7cafb511-0ab7-f3b4-e053-2991aa0a2e0b	set_id
unii		R533ESO2EC	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only Ask a doctor before use if condition covers a large area of the body. When using this product avoid contact with the eyes. If contact occurs, rinse eyes thoroughly with water. use caution in exposing skin to sunlight. It may increase your tendency to sunburn for up to 24 hours after application. do not use with other forms of psoriasis therapy such as ultraviolet radiation or prescription drugs unless directed by a physician. do not use for prolonged periods without consulting a physician. Stop use and ask a doctor if condition worsens. condition does not improve after regular use of this product as directed. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center immediately. WARNING: This product can expose you to chemicals including Coal Tar, which is known to the State of California to cause cancer. For more information go to www.P65Warnings.ca.gov

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.